CervoMed (CRVO) Research & Development (2022 - 2025)
Historic Research & Development for CervoMed (CRVO) over the last 8 years, with Q3 2025 value amounting to $6.0 million.
- CervoMed's Research & Development rose 1786.01% to $6.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $23.1 million, marking a year-over-year increase of 5839.44%. This contributed to the annual value of $18.8 million for FY2024, which is 12276.88% up from last year.
- Per CervoMed's latest filing, its Research & Development stood at $6.0 million for Q3 2025, which was up 1786.01% from $5.1 million recorded in Q2 2025.
- In the past 5 years, CervoMed's Research & Development registered a high of $7.1 million during Q4 2024, and its lowest value of $330543.0 during Q3 2022.
- In the last 4 years, CervoMed's Research & Development had a median value of $2.9 million in 2023 and averaged $3.4 million.
- Its Research & Development has fluctuated over the past 5 years, first soared by 65005.58% in 2023, then soared by 1786.01% in 2025.
- Quarter analysis of 4 years shows CervoMed's Research & Development stood at $380685.0 in 2022, then skyrocketed by 650.06% to $2.9 million in 2023, then skyrocketed by 148.19% to $7.1 million in 2024, then decreased by 14.76% to $6.0 million in 2025.
- Its Research & Development was $6.0 million in Q3 2025, compared to $5.1 million in Q2 2025 and $4.8 million in Q1 2025.